Short description of important scientific result: Dr. Deneka is conducting research, dedicated to investigation of the mechanisms by which intracellular regulatory proteins - stem cell markers, translational regulators (such as the Musashi family proteins) and scaffolding proteins (Nedd9) regulate growth, metastasis and response of human cancer cells targeted agents and chemotherapy. Recent work includes a functional analysis of complex signaling networks, the purpose of which is is to understand the causes of metastasis of non-small cell lung cancer. In collaboration with Dr. Y. Boumber at KFU and Dr. E.A. Golemis at the Fox Chase Cancer Center, the team identified Musashi 2 protein (MSI2) as a driver of progression of non-small cell lung cancer (NSCLC), and revealed its biological role in maintaining the activity of EGFR in EGFR-mutant NSCLC. These discoveries are of great scientific and practical importance, since resistance to targeted therapy of EGFR mutant NSCLC is steadily increasing, and further preclinical and, in the future,